Activated Epac and Rap1 are Novel Inhibitors of Tumor Angiogenesis

Authors

Robert C. Doebele, University of ColoradoFollow
Jia Hong, University of Chicago
Mark W. Lingen, University of ChicagoFollow
Benjamin David Zeitlin, University of the PacificFollow
Jacques E. Nör, University of Michigan School of DentistryFollow
Yuru Liu, University of ChicagoFollow
Mark K. Abe, University of ChicagoFollow
Marsha Rich Rosner, University of ChicagoFollow

ORCiD

Dr. Benjamin D. Zeitlin: 0000-0003-0110-0188

Department

Biomedical Sciences

Document Type

Conference Presentation

Conference Title

Keystone Symposia on Molecular Targets for Cancer

Location

Whistler, British Columbia Canada

Conference Dates

March 18-23, 2007

Date of Presentation

3-18-2007

Comments

Conference Program: https://www.keystonesymposia.org/index.cfm?e=Web.Meeting.Program&MeetingID=822

Recommended Citation

Doebele, R. C., Hong, J., Lingen, M. W., Zeitlin, B. D., Nör, J. E., Liu, Y., Abe, M. K., & Rosner, M. R. (2007). Activated Epac and Rap1 are Novel Inhibitors of Tumor Angiogenesis. Paper presented at Keystone Symposia on Molecular Targets for Cancer in Whistler, British Columbia Canada.
https://scholarlycommons.pacific.edu/dugoni-facpres/89